Evidence for dissociation of insulin- and weight-reducing effects of metformin in non-diabetic male patients with coronary heart disease (Q47288924)

13 January 2018

title

Evidence for dissociation of insulin- and weight-reducing effects of metformin in non-diabetic male patients with coronary heart disease (English)

1 reference

13 January 2018

1 reference

Carlsen SM

1

1 reference

13 January 2018

Grill V

series ordinal

2

1 reference

13 January 2018

Følling I

series ordinal

3

1 reference

13 January 2018

publication date

1 January 1998

1 reference

13 January 2018

Diabetes Research and Clinical Practice

published in

1 reference

13 January 2018

volume

39

1 reference

13 January 2018

issue

1

1 reference

13 January 2018

page(s)

47-54

1 reference

13 January 2018

Relationship of Glucose Tolerance and Plasma Insulin to the Incidence of Coronary Heart Disease: Results from Two Population Studies in Finland

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900121-6

7 January 2021

Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900121-6

7 January 2021

Risk factors for early death in non-insulin dependent diabetes and men with known glucose tolerance status

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900121-6

7 January 2021

Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900121-6

7 January 2021

The relationship of cardiovascular risk factors to the prevalence of coronary heart disease in newly diagnosed type 2 (non-insulin-dependent) diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900121-6

7 January 2021

Effect of insulin in the induction and regression of experimental cholesterol atherosclerosis in the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900121-6

7 January 2021

Effect of intra-arterial insulin on tissue cholesterol and fatty acids in alloxan-diabetic dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900121-6

7 January 2021

Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900121-6

7 January 2021

Metformin improves glucose, lipid metabolism, and reduces blood pressure in hypertensive, obese women.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900121-6

7 January 2021

Metformin improves blood lipid pattern in nondiabetic patients with coronary heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900121-6

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900121-6

7 January 2021

Study of the Relationship Between Glucose and Insulin Responses to an Oral Glucose Load in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900121-6

7 January 2021

Lack of effect of intravenous metformin on plasma concentrations of glucose, insulin, C-peptide, glucagon and growth hormone in non-diabetic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900121-6

7 January 2021

Short administration of metformin improves insulin sensitivity in android obese subjects with impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900121-6

7 January 2021

10.1016/S0168-8227(97)00121-6

Identifiers

DOI

1 reference

13 January 2018

1 reference

13 January 2018